Biochemical modulation of 5-fluorouacil through dihydropyrimidine dehydrogenase inhibition: a Southwest Oncology Group phase II trial of eniluracil and 5-fluorouracil in advanced resistant colorectal cancer. [electronic resource]
Producer: 20030421Description: 419-24 p. digitalISSN:- 0167-6997
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Antineoplastic Protocols
- Colorectal Neoplasms -- drug therapy
- Confidence Intervals
- Dihydrouracil Dehydrogenase (NADP)
- Enzyme Inhibitors -- adverse effects
- Female
- Fluorouracil -- adverse effects
- Humans
- Male
- Middle Aged
- Oxidoreductases -- antagonists & inhibitors
- Southwestern United States
- Survival Rate
- Treatment Failure
- Uracil -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.